High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

Saved in:
Bibliographic Details
Title: High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
Authors: Rogers CL; Department of Radiation Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona. Electronic address: Neuropub@barrowneuro.org., Won M; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Vogelbaum MA; Moffitt Cancer Center, Tampa, Florida., Perry A; University of California-San Francisco, San Francisco, California., Ashby LS; Saint Joseph's Hospital and Medical Center, Phoenix, Arizona., Modi JM; Yale New Haven Hospital, New Haven, Connecticut., Alleman AM; The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Galvin J; IROC Philadelphia, Philadelphia, Pennsylvania., Fogh SE; University of California-San Francisco, San Francisco, California., Youssef E; Department of Radiation Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona., Deb N; Department of Radiation Oncology, St. Luke's University Health Network, Bethlehem, Pennsylvania., Kwok Y; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland., Robinson CG; Washington University, St. Louis, Missouri., Shu HK; Emory University, Atlanta, Georgia., Fisher BJ; London Regional Cancer Program, London, Ontario, Canada., Panet-Raymond V; McGill University, Montréal, Québec, Canada., McMillan WG; Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada., de Groot JF; University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang P; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Mehta MP; Miami Cancer Institute, Baptist Health, Miami, Florida.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 15; Vol. 106 (4), pp. 790-799. Date of Electronic Publication: 2019 Nov 29.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-355X
DOI:10.1016/j.ijrobp.2019.11.028